Hälsa & medicin

Researchers have identified a way to block a protein called OGG1 that appears to drive pulmonary fibrosis, a fatal lung disease affecting hundreds of thousands globally. The finding could lead to the first effective treatment for a condition that currently has no cure and kills patients within 2-5 years of diagnosis.EN

Researchers identified a metabolic pathway that can reprogram immune cells to better attack tumors. The discovery could lead to new cancer treatments that work alongside existing immunotherapies, potentially offering patients another option when standard approaches fail or resistance develops.EN

Researchers comparing two protein biomarkers found that serum glial fibrillary acidic protein may better predict disease progression in multiple sclerosis patients than the current standard. The finding could help doctors identify patients at risk of worsening disease and adjust treatment strategies earlier, potentially reducing disability and improving patient outcomes.EN

A major medical consensus statement standardizes how clinicians identify and categorize metabolic hyperferritinaemia, a condition linked to iron overload. The unified definition should improve diagnosis accuracy across hospitals and enable better tracking of treatments—critical for pharmaceutical companies developing iron-management drugs and healthcare systems managing patient care.EN

Researchers compared high-dose and low-dose exercise programs for knee osteoarthritis patients and found both approaches delivered similar pain relief. The finding could reshape physical therapy guidelines and reduce unnecessary healthcare spending by letting patients choose less intensive routines without sacrificing outcomes.EN

A new international repository tracking breast, cervical, and colorectal cancer screening across 84 countries exposes stark inequalities: screening coverage ranges from under 1% to over 85% depending on cancer type and location. The findings highlight critical gaps in how countries measure and report screening effectiveness, creating blind spots for policymakers trying to improve cancer outcomes.EN

A mouse study reveals that age and pregnancy history change how blood vessels form in the ovary, potentially affecting fertility and reproductive health. The findings could inform treatment strategies for age-related infertility and guide development of therapies targeting ovarian aging.EN

A major study in JAMA finds that women with histories of miscarriage, stillbirth, or preeclampsia show higher rates of coronary artery disease later in life. The finding could reshape how clinicians screen women's cardiac risk and how insurers and employers approach preventive health programs for female workers.EN

Researchers tracking millions of patients across four Nordic countries have documented clinical outcomes of myocarditis—inflammation of the heart muscle—following mRNA vaccination. The findings provide health authorities and insurers with population-level evidence to refine risk communication and monitoring protocols for post-vaccination cardiac events.EN

Scientists have discovered that suppression of a tumor-suppressing gene called ARF by the MYC protein—but not its relative MYCN—drives aggressive pediatric brain tumors. The finding could reshape how doctors diagnose and treat the most lethal childhood cancers, potentially allowing more precise treatment selection and opening new drug targets for pharmaceutical development.EN

Researchers have identified a quick, low-cost drawing test that reliably detects cognitive decline in people at genetic risk for frontotemporal dementia before symptoms fully emerge. The finding could enable earlier clinical interventions and help pharmaceutical companies design trials targeting at-risk populations more precisely.EN

Researchers have identified critical gaps in both patient recognition and healthcare system response that postpone diagnosis of advanced oral, throat, and laryngeal cancers. The findings suggest that reducing these delays could significantly improve survival rates and outcomes—a potential priority for hospital administrators and policymakers overseeing cancer care pathways.EN

Researchers identified genetic markers that distinguish children with alpha-1 antitrypsin deficiency who develop severe liver damage from those who remain stable. The findings could enable earlier intervention and personalized monitoring, potentially reducing costly complications and transplant needs in a rare genetic disorder affecting thousands.EN

Researchers analyzing 1,500+ oropharyngeal cancer patients found that traditional HPV testing alone misses critical cases, suggesting doctors need a dual-marker approach using p16 alongside HPV status. The finding could refine patient stratification for treatment intensity and improve survival predictions—potentially affecting treatment protocols, clinical trial design, and pharmaceutical development strategies in oncology.EN

Scientists have uncovered previously unknown genetic vulnerabilities linked to primary sclerosing cholangitis, a rare autoimmune liver condition, and pinpointed candidate drugs that could be repurposed to treat it. The findings could accelerate drug development for a disease with no cure and limited treatment options.EN

Researchers have identified distinct molecular differences between two forms of aortic valve degeneration, suggesting that a one-size-fits-all treatment approach won't work. The finding opens a path toward personalized therapies for a condition that currently has no medical treatment and affects hundreds of thousands of patients globally.EN

Scientists have identified a class of autoantibodies targeting G protein-coupled receptors that drive disease in cardiovascular, kidney, and autoimmune conditions—yet also appear in healthy individuals. The finding could reshape how companies develop diagnostics and therapeutics by revealing that these antibodies play a dual role in disease progression rather than simply causing illness.EN

Researchers have identified a life-threatening immune syndrome occurring in patients receiving cellular therapies—a finding that could reshape safety monitoring protocols across the transplant and CAR-T cell industries. The discovery highlights a critical gap in how hospitals screen for and manage rare but severe immune complications, with implications for clinical practice and regulatory oversight.EN

Researchers have identified a promising approach to inflammatory skin conditions by blocking IRAK4, a protein that orchestrates immune responses. The finding, tested across multiple disease models and validated in human cells, could open a new treatment pathway for conditions like psoriasis and eczema that currently have limited options.EN

A major review from Keystone Symposia identifies breakthrough developments in vaccine science that could reshape how the industry approaches infectious disease prevention. The findings come as governments and manufacturers race to strengthen pandemic preparedness and expand immunization beyond traditional targets.EN

Researchers identified the molecular pathways that trigger IgA nephropathy, a leading cause of kidney failure worldwide, using genome-wide analysis. The findings pinpoint specific drug targets that could halt disease progression, potentially reducing dialysis demand and offering pharma companies new therapeutic opportunities in a disease affecting millions.EN

Scientists have identified a broadly neutralizing antibody, 19n01, that works against omicron subvariants and other concerning SARS-CoV-2 strains. The finding could inform next-generation vaccine design and therapeutic development as the virus continues to evolve, potentially reducing the need for frequent vaccine reformulations.EN

A large genetic analysis found no causal link between caffeine consumption and obesity, type 2 diabetes, or heart disease—challenging long-held health assumptions. The finding could reshape beverage industry regulations and workplace wellness programs built on caffeine restrictions.EN

Researchers used advanced imaging to capture rotavirus assembly in real time, revealing the step-by-step process of how this common pathogen builds itself. The findings could accelerate development of better vaccines and antiviral treatments for a virus that kills hundreds of thousands of children annually in developing countries.EN

People with a family history of depression show measurable differences in cognitive function, according to research in JAMA Psychiatry. The finding could reshape how insurers, employers, and healthcare systems identify and support at-risk populations before serious mental health problems emerge.EN